Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma

Glioblastoma multiforme (GBM) is the most aggressive primary central nervous system malignant tumor. The median survival of GBM patients is 12–15 months, and the 5 years survival rate is less than 5%. More novel molecular biomarkers are still urgently required to elucidate the mechanisms or improve...

Full description

Bibliographic Details
Main Authors: Wen Yin, Guihua Tang, Quanwei Zhou, Yudong Cao, Haixia Li, Xianyong Fu, Zhaoping Wu, Xingjun Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Genetics
Subjects:
glioblastoma
differentially expressed genes
gene signature
prognosis
TCGA
GEO
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2019.00419/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2019.00419/full

Similar Items